Starling Oncology, Inc. (STLN) vs U.S. Physical Therapy, Inc. (USPH)
- Starling Oncology, Inc. STLN 6.43 −6.95%
- U.S. Physical Therapy, Inc. USPH 85.71 −0.31%
Starling Oncology, Inc. and U.S. Physical Therapy, Inc. are both Medical Care Facilities companies. U.S. Physical Therapy, Inc. is the larger, with a market value of $1.3B against $690.9M — 1.9× the size. Starling Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; U.S. Physical Therapy, Inc. trades at 504×. Starling Oncology, Inc. grew revenue faster over the last twelve months: 38.4% against 11.3%. U.S. Physical Therapy, Inc. has the higher net margin (2.54% vs −6.18%) and the higher return on invested capital (7.48% vs −117.7%). Across the 18 metrics below, Starling Oncology, Inc. leads on 9 and U.S. Physical Therapy, Inc. on 9.
Valuation
Profitability
| Metric | STLN | USPH | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 15.69% | 18.68% | 30.78% |
| Operating margin | (4.44%) | 9.42% | 5.74% |
| Net margin | (6.18%) | 2.54% | 2.32% |
| Free cash flow margin | (0.56%) | 7.89% | 5.46% |
| Return on equity | 214.12% | 4.34% | 8.76% |
| Return on assets | (21.47%) | 1.70% | 2.18% |
| Return on invested capital | (117.66%) | 7.48% | 5.01% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack